Human CCR7 Full Length Protein (VLP)

Customer Reviews
Cat. No. / Size
Price
Qty
CC7-H52P3-20ug
$620.00
CC7-H52P3-100ug
$1235.00
CC7-H52P3-500ug (250ug X 2)
$4305.00
ETA of in-stock products:2 business days

Product Details

  • Application

    1. Immunization
    2. Cell based assay (FACS or functional assay)
    3. Screening (ELISA)
  • Synonyms

    BLR2, CC-CKR-7, CCR-7, CD197, CDw197, CMKBR7, EBI1

  • Source

    Human CCR7 Full Length Protein (VLP) (CC7-H52P3) is expressed from human 293 cells (HEK293). It contains AA Gln 25 - Pro 378 (Accession # P32248).

    Predicted N-terminus: Asp

  • Molecular Characterization

    *The isotype control of empty/mock VLP (Cat. No. VLP-N5213) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.

    2. Synthesis Process

      Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Formulation

    The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).

    Supplied as 0.2 μm filtered solution in PBS, Arginine, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 12 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Bioactivity-ELISA

     CCR7 ELISA

    Immobilized Human CCR7 Full Length Protein (VLP) (Cat. No. CC7-H52P3) at 5 μg/mL (100 μL/well) can bind Monoclonal Anti-CCR7 Antibody, Human IgG1 with a linear range of 1-63 ng/mL (QC tested).

    Protocol
  • Identity-DLS

     CCR7 DLS

    The mean peak Radius of VLP is 105-125 nm with more than 95% intensity as determined by dynamic light scattering (DLS).

Customer Reviews
Writing Reviews

Background

CCR7 is central chemokine receptor orchestrating homing of T cells and dendritic cells to lymph nodes via CCL19/CCL21. It is essential for adaptive immunity initiation. In cancer, CCR7 expression facilitates lymph node metastasis of melanoma, breast, and gastric cancers, making it a target to block lymphatic spread.

Recent Advances

 
Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland